Cyclerion Therapeutics Inc. (CYCN)
Market Open
12 Jun, 13:38
NASDAQ (CM) NASDAQ (CM) Primary $
3. 14
-0.07
-2.215%
$
13.25M Market Cap
- P/E Ratio
- Div Yield
659 Volume
0 Eps
$ 3.21
Previous Close Investors:
Want to track CYCN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cyclerion Therapeutics Inc. (CYCN) Statistics
Valuation metrics
Market Cap 13.25M
Enterprise value 10.08M
Trailing P/E (ttm) -2.38
Forward P/E -
PEG ratio 0.04
Price/Sales (ttm) 6.47
Price/Book (mrq) 1.85
Enterprise Value/Revenue 5.06
Enterprise Value/EBITDA -1.51
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 24.16K
Average volume (90 days) 5.24M
Price summary
52-Week low 1.03
52-Week high 8.48
Beta -
50-Day moving average 3.11
200-Day moving average 1.99
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 16 May 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2.65%
Operating margin -3.37%
Operational effectiveness
Return on assets -0.62%
Return on equity -0.62%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.47
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.25
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.67
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 1.8%
Book value per share (mrq) 1.61
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
